NIAID renews funding for the Adult AIDS Clinical Trials Group
The Adult AIDS Clinical Trials Group will receive $80 million in funding to continue studying antiviral interventions, immune system restoration, and opportunistic disease prevention. The network aims to improve patients' abilities to tolerate therapies and develop new strategies for treating HIV-related complications.